Page last updated: 2024-09-05

orbofiban and clopidogrel

orbofiban has been researched along with clopidogrel in 1 studies

Compound Research Comparison

Studies (orbofiban)	Trials (orbofiban)	Recent Studies (post-2010) (orbofiban)	Studies (clopidogrel)	Trials (clopidogrel)	Recent Studies (post-2010) (clopidogrel)
48	17	0	10,221	1,918	5,951

Protein Interaction Comparison

Protein	Taxonomy	orbofiban (IC50)	clopidogrel (IC50)
Sodium-dependent serotonin transporter	Homo sapiens (human)		0.562
P2Y purinoceptor 12	Homo sapiens (human)		2.4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ferguson, JJ	1

Other Studies

1 other study(ies) available for orbofiban and clopidogrel

Article	Year
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology. Circulation, 1999, Aug-10, Volume: 100, Issue:6 Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E	1999

Article

Year

Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.

Circulation, 1999, Aug-10, Volume: 100, Issue:6

Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E

1999